Deborah York, NP

NPI: 1952823403
Total Payments
$147,514
2024 Payments
$69,047
Companies
11
Transactions
332

Payment Breakdown by Category

Other$103,102 (69.9%)
Travel$31,523 (21.4%)
Food & Beverage$7,889 (5.3%)
Consulting$5,000 (3.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $103,102 56 69.9%
Travel and Lodging $31,523 136 21.4%
Food and Beverage $7,889 138 5.3%
Consulting Fee $5,000 2 3.4%

Top Paying Companies

Company Total Records Latest Year
Vanda Pharmaceuticals Inc. $68,622 124 $0 (2024)
Alkermes, Inc. $36,499 87 $0 (2024)
ABBVIE INC. $29,545 89 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $7,299 12 $0 (2024)
Neurocrine Biosciences, Inc. $3,552 5 $0 (2024)
Sunovion Pharmaceuticals Inc. $848.35 7 $0 (2022)
Allergan, Inc. $825.00 1 $0 (2021)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $141.70 2 $0 (2024)
Biogen, Inc. $68.54 1 $0 (2024)
ITI, Inc. $60.48 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $69,047 133 Vanda Pharmaceuticals Inc. ($68,029)
2023 $22,929 70 ABBVIE INC. ($11,875)
2022 $38,843 81 Alkermes, Inc. ($22,902)
2021 $16,696 48 AbbVie Inc. ($9,262)

All Payment Transactions

332 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.55 General
Category: NEUROSCIENCE
12/11/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,800.00 General
Category: SCHIZOPHRENIA
12/11/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $119.59 General
Category: SCHIZOPHRENIA
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,250.00 General
Category: SCHIZOPHRENIA
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $399.46 General
Category: SCHIZOPHRENIA
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $142.07 General
Category: SCHIZOPHRENIA
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $126.86 General
Category: SCHIZOPHRENIA
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: SCHIZOPHRENIA
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $12.32 General
Category: SCHIZOPHRENIA
12/03/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $441.95 General
Category: SCHIZOPHRENIA
11/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,250.00 General
Category: SCHIZOPHRENIA
11/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $348.22 General
Category: SCHIZOPHRENIA
11/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $291.55 General
Category: SCHIZOPHRENIA
11/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $173.98 General
Category: SCHIZOPHRENIA
11/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $113.00 General
Category: SCHIZOPHRENIA
11/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $40.20 General
Category: SCHIZOPHRENIA
11/08/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $104.17 General
Category: CNS
11/07/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $92.59 General
Category: CNS
11/06/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $126.69 General
Category: Neuropsychiatry
10/30/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,250.00 General
Category: SCHIZOPHRENIA
10/30/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $641.96 General
Category: SCHIZOPHRENIA
10/30/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $126.15 General
Category: SCHIZOPHRENIA
10/30/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $124.73 General
Category: SCHIZOPHRENIA
10/30/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Travel and Lodging Cash or cash equivalent $100.10 General
Category: SCHIZOPHRENIA
10/30/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $63.66 General
Category: SCHIZOPHRENIA

About Deborah York, NP

Deborah York, NP is a Psychiatric/Mental Health healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952823403.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deborah York, NP has received a total of $147,514 in payments from pharmaceutical and medical device companies, with $69,047 received in 2024. These payments were reported across 332 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($103,102).

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Denver, CO
  • Active Since 07/16/2017
  • Last Updated 03/11/2025
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1952823403

Products in Payments

  • FANAPT (Drug) $68,622
  • LYBALVI (Drug) $35,870
  • VRAYLAR (Drug) $30,330
  • INGREZZA (Drug) $3,428
  • ARISTADA (Drug) $509.41
  • CAPLYTA (Drug) $202.18
  • ONGENTYS (Drug) $123.22
  • Vivitrol (Drug) $119.47
  • ZURZUVAE (Drug) $68.54
  • LATUDA (Drug) $55.85
  • Auvelity (Drug) $53.38

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Denver